Xeris Biopharma Holdings Inc (XERS)
3.04
-0.02
(-0.65%)
USD |
NASDAQ |
Nov 21, 16:00
3.045
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Market Cap: 453.21M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 453.21M |
| November 20, 2024 | 456.19M |
| November 19, 2024 | 448.74M |
| November 18, 2024 | 432.34M |
| November 15, 2024 | 435.32M |
| November 14, 2024 | 454.70M |
| November 13, 2024 | 469.61M |
| November 12, 2024 | 469.61M |
| November 11, 2024 | 488.99M |
| November 08, 2024 | 517.31M |
| November 07, 2024 | 500.91M |
| November 06, 2024 | 497.93M |
| November 05, 2024 | 486.01M |
| November 04, 2024 | 480.04M |
| November 01, 2024 | 481.53M |
| October 31, 2024 | 480.04M |
| October 30, 2024 | 481.28M |
| October 29, 2024 | 481.28M |
| October 28, 2024 | 481.28M |
| October 25, 2024 | 476.81M |
| October 24, 2024 | 482.77M |
| October 23, 2024 | 463.40M |
| October 22, 2024 | 449.99M |
| October 21, 2024 | 451.48M |
| October 18, 2024 | 455.95M |
| Date | Value |
|---|---|
| October 17, 2024 | 452.97M |
| October 16, 2024 | 452.97M |
| October 15, 2024 | 449.99M |
| October 14, 2024 | 442.54M |
| October 11, 2024 | 433.60M |
| October 10, 2024 | 414.23M |
| October 09, 2024 | 418.70M |
| October 08, 2024 | 438.07M |
| October 07, 2024 | 436.58M |
| October 04, 2024 | 444.03M |
| October 03, 2024 | 444.03M |
| October 02, 2024 | 433.60M |
| October 01, 2024 | 415.72M |
| September 30, 2024 | 424.66M |
| September 27, 2024 | 427.63M |
| September 26, 2024 | 421.67M |
| September 25, 2024 | 417.20M |
| September 24, 2024 | 420.18M |
| September 23, 2024 | 411.24M |
| September 20, 2024 | 436.57M |
| September 19, 2024 | 441.04M |
| September 18, 2024 | 432.10M |
| September 17, 2024 | 432.10M |
| September 16, 2024 | 429.12M |
| September 13, 2024 | 429.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
55.98M
Minimum
Mar 18 2020
517.31M
Maximum
Nov 08 2024
262.37M
Average
258.92M
Median
Market Cap Benchmarks
| Zevra Therapeutics Inc | 487.32M |
| NovaBay Pharmaceuticals Inc | 3.517M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.562M |
Market Cap Related Metrics
| PS Ratio | 2.336 |
| Price | 3.04 |
| Earnings Yield | -14.47% |